MDxHealth (MDXH) Cost of Revenue (2021 - 2026)

MDxHealth has reported Cost of Revenue for 6 years, with the latest figure at $10.8 million in Q1 2026.

• Quarterly Cost of Revenue rose 22.58% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.1 million (up 61.59% YoY) and the FY2025 annual result came in at $38.2 million, up 9.55% from the prior year.
• Cost of Revenue retreated to $10.8 million in Q1 2026 per MDXH's latest filing, from $10.9 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $27.4 million in Q3 2025 and troughed at -$3.3 million in Q2 2022.
• A 5-year average of $8.2 million and a median of $7.8 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue surged 307.48% in 2023, then advanced 1.86% in 2025.
• Over 5 years, Cost of Revenue stood at $5.7 million in 2022, then grew by 18.7% to $6.7 million in 2023, then surged by 37.09% to $9.2 million in 2024, then grew by 17.74% to $10.9 million in 2025, then slipped by 0.79% to $10.8 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $10.8 million, $10.9 million, and $27.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.